Vaccine For HPV Virus Being Tested In Clinical Trials

Etubics Corporation has received a $1.03 million grant from the National Institutes of Health (NIH) to move a vaccine for human papilloma virus (HPV) developed by a Sanford researcher to clinical trials. The vaccine was engineered by Sanford Research's John Lee and his team in collaboration with Etubics. Dr. John Lee discusses the vaccine.